Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
156M
-
Shares change
-
-8.94M
-
Total reported value, excl. options
-
$229M
-
Value change
-
-$26M
-
Put/Call ratio
-
0
-
Number of buys
-
101
-
Number of sells
-
-114
-
Price
-
$1.47
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q1 2025
257 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q1 2025.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 156M shares
of 162M outstanding shares and own 96.06% of the company stock.
Largest 10 shareholders include Sarissa Capital Management LP (16.4M shares), VANGUARD GROUP INC (15.7M shares), ARMISTICE CAPITAL, LLC (13.7M shares), BlackRock, Inc. (11.9M shares), RENAISSANCE TECHNOLOGIES LLC (9.94M shares), BRAIDWELL LP (6.62M shares), MILLENNIUM MANAGEMENT LLC (6.36M shares), Kynam Capital Management, LP (5.82M shares), LSV ASSET MANAGEMENT (4M shares), and JANE STREET GROUP, LLC (3.51M shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.